Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000125239 | SCV000168680 | benign | not specified | 2013-12-09 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000894640 | SCV001038637 | benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002498603 | SCV002808516 | likely benign | Combined oxidative phosphorylation deficiency 39 | 2022-03-02 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000894640 | SCV004011601 | benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | GFM2: BP4, BS1, BS2 |
Breakthrough Genomics, |
RCV000894640 | SCV005302183 | benign | not provided | criteria provided, single submitter | not provided |